Fukano, Y; Kawazu, K (2009). “Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats”. Drug Metabolism and Disposition37 (8): 1622–34. doi:10.1124/dmd.108.024885. PMID19477946.
Fukano, Y; Kawazu, K; Akaishi, T; Bezwada, P; Pellinen, P (2011). “Metabolism and ocular tissue distribution of an antiglaucoma prostanoid, tafluprost, after ocular instillation to monkeys”. Journal of Ocular Pharmacology and Therapeutics27 (3): 251–9. doi:10.1089/jop.2010.0178. PMID21491995.
nih.gov
pubmed.ncbi.nlm.nih.gov
Fukano, Y; Kawazu, K (2009). “Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats”. Drug Metabolism and Disposition37 (8): 1622–34. doi:10.1124/dmd.108.024885. PMID19477946.
Fukano, Y; Kawazu, K; Akaishi, T; Bezwada, P; Pellinen, P (2011). “Metabolism and ocular tissue distribution of an antiglaucoma prostanoid, tafluprost, after ocular instillation to monkeys”. Journal of Ocular Pharmacology and Therapeutics27 (3): 251–9. doi:10.1089/jop.2010.0178. PMID21491995.